 | • レポートコード：MRC2-11QY12665 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は転移性がん治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、生物学的標的療法、乳腺手術、ホルモン療法）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別転移性がん治療の競争状況、市場シェア ・世界の転移性がん治療市場：種類別市場規模 2015年-2020年（化学療法、放射線療法、生物学的標的療法、乳腺手術、ホルモン療法） ・世界の転移性がん治療市場：種類別市場規模予測 2021年-2026年（化学療法、放射線療法、生物学的標的療法、乳腺手術、ホルモン療法） ・世界の転移性がん治療市場：用途別市場規模 2015年-2020年（病院、クリニック、その他） ・世界の転移性がん治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、その他） ・北米の転移性がん治療市場分析：米国、カナダ ・ヨーロッパの転移性がん治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの転移性がん治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の転移性がん治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの転移性がん治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、Novartis、Merck、Eli Lilly、Johnson & Johnson、Pfizer、AstraZeneca、GlaxoSmithKline、Sun Pharmaceutical、Bayer、Gilead Sciences ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast cancer. Although cancer has spread to other parts of the body, but it is treated as breast cancer only. Usually, metastatic breast cancer occurs months or years after completion of treatment for early or locally advanced stages of breast cancer. Metastatic breast cancer cannot be cured. As it has spread to other organs, so it becomes impossible to get rid of all types of cancer. But the treatment of metastatic breast cancer can extend patient’s life with increasing quality of life. Treatment of metastatic breast cancer is influenced by factors such as symptoms, past treatments, cancer cell characteristics and organs affected.
Market Analysis and Insights: Global Metastatic Cancer Treatment Market
The global Metastatic Cancer Treatment market size is projected to reach US$ 52620 million by 2026, from US$ 50230 million in 2020, at a CAGR of 4.4%% during 2021-2026.
Global Metastatic Cancer Treatment Scope and Market Size
Metastatic Cancer Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Metastatic Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche
Novartis
Merck
Eli Lilly
Johnson & Johnson
Pfizer
AstraZeneca
GlaxoSmithKline
Sun Pharmaceutical
Bayer
Gilead Sciences
Market segment by Type, the product can be split into
Chemotherapy
Radiation Therapy
Biologic Targeted Therapy
Breast Surgery
Hormone Therapy
Market segment by Application, split into
Hospitals
Clinics
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Metastatic Cancer Treatment Revenue
1.4 Market by Type
1.4.1 Global Metastatic Cancer Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Radiation Therapy
1.4.4 Biologic Targeted Therapy
1.4.5 Breast Surgery
1.4.6 Hormone Therapy
1.5 Market by Application
1.5.1 Global Metastatic Cancer Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Metastatic Cancer Treatment Market Perspective (2015-2026)
2.2 Global Metastatic Cancer Treatment Growth Trends by Regions
2.2.1 Metastatic Cancer Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Metastatic Cancer Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Metastatic Cancer Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Metastatic Cancer Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Metastatic Cancer Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Metastatic Cancer Treatment Players by Market Size
3.1.1 Global Top Metastatic Cancer Treatment Players by Revenue (2015-2020)
3.1.2 Global Metastatic Cancer Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Metastatic Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Metastatic Cancer Treatment Market Concentration Ratio
3.2.1 Global Metastatic Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Metastatic Cancer Treatment Revenue in 2019
3.3 Metastatic Cancer Treatment Key Players Head office and Area Served
3.4 Key Players Metastatic Cancer Treatment Product Solution and Service
3.5 Date of Enter into Metastatic Cancer Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Metastatic Cancer Treatment Historic Market Size by Type (2015-2020)
4.2 Global Metastatic Cancer Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Metastatic Cancer Treatment Market Size by Application (2015-2020)
5.2 Global Metastatic Cancer Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Metastatic Cancer Treatment Market Size (2015-2020)
6.2 Metastatic Cancer Treatment Key Players in North America (2019-2020)
6.3 North America Metastatic Cancer Treatment Market Size by Type (2015-2020)
6.4 North America Metastatic Cancer Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Metastatic Cancer Treatment Market Size (2015-2020)
7.2 Metastatic Cancer Treatment Key Players in Europe (2019-2020)
7.3 Europe Metastatic Cancer Treatment Market Size by Type (2015-2020)
7.4 Europe Metastatic Cancer Treatment Market Size by Application (2015-2020)
8 China
8.1 China Metastatic Cancer Treatment Market Size (2015-2020)
8.2 Metastatic Cancer Treatment Key Players in China (2019-2020)
8.3 China Metastatic Cancer Treatment Market Size by Type (2015-2020)
8.4 China Metastatic Cancer Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Metastatic Cancer Treatment Market Size (2015-2020)
9.2 Metastatic Cancer Treatment Key Players in Japan (2019-2020)
9.3 Japan Metastatic Cancer Treatment Market Size by Type (2015-2020)
9.4 Japan Metastatic Cancer Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Metastatic Cancer Treatment Market Size (2015-2020)
10.2 Metastatic Cancer Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Metastatic Cancer Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Metastatic Cancer Treatment Market Size by Application (2015-2020)
11 India
11.1 India Metastatic Cancer Treatment Market Size (2015-2020)
11.2 Metastatic Cancer Treatment Key Players in India (2019-2020)
11.3 India Metastatic Cancer Treatment Market Size by Type (2015-2020)
11.4 India Metastatic Cancer Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Metastatic Cancer Treatment Market Size (2015-2020)
12.2 Metastatic Cancer Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Metastatic Cancer Treatment Market Size by Type (2015-2020)
12.4 Central & South America Metastatic Cancer Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview
13.1.3 Roche Metastatic Cancer Treatment Introduction
13.1.4 Roche Revenue in Metastatic Cancer Treatment Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Metastatic Cancer Treatment Introduction
13.2.4 Novartis Revenue in Metastatic Cancer Treatment Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Merck
13.3.1 Merck Company Details
13.3.2 Merck Business Overview
13.3.3 Merck Metastatic Cancer Treatment Introduction
13.3.4 Merck Revenue in Metastatic Cancer Treatment Business (2015-2020)
13.3.5 Merck Recent Development
13.4 Eli Lilly
13.4.1 Eli Lilly Company Details
13.4.2 Eli Lilly Business Overview
13.4.3 Eli Lilly Metastatic Cancer Treatment Introduction
13.4.4 Eli Lilly Revenue in Metastatic Cancer Treatment Business (2015-2020)
13.4.5 Eli Lilly Recent Development
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Details
13.5.2 Johnson & Johnson Business Overview
13.5.3 Johnson & Johnson Metastatic Cancer Treatment Introduction
13.5.4 Johnson & Johnson Revenue in Metastatic Cancer Treatment Business (2015-2020)
13.5.5 Johnson & Johnson Recent Development
13.6 Pfizer
13.6.1 Pfizer Company Details
13.6.2 Pfizer Business Overview
13.6.3 Pfizer Metastatic Cancer Treatment Introduction
13.6.4 Pfizer Revenue in Metastatic Cancer Treatment Business (2015-2020)
13.6.5 Pfizer Recent Development
13.7 AstraZeneca
13.7.1 AstraZeneca Company Details
13.7.2 AstraZeneca Business Overview
13.7.3 AstraZeneca Metastatic Cancer Treatment Introduction
13.7.4 AstraZeneca Revenue in Metastatic Cancer Treatment Business (2015-2020)
13.7.5 AstraZeneca Recent Development
13.8 GlaxoSmithKline
13.8.1 GlaxoSmithKline Company Details
13.8.2 GlaxoSmithKline Business Overview
13.8.3 GlaxoSmithKline Metastatic Cancer Treatment Introduction
13.8.4 GlaxoSmithKline Revenue in Metastatic Cancer Treatment Business (2015-2020)
13.8.5 GlaxoSmithKline Recent Development
13.9 Sun Pharmaceutical
13.9.1 Sun Pharmaceutical Company Details
13.9.2 Sun Pharmaceutical Business Overview
13.9.3 Sun Pharmaceutical Metastatic Cancer Treatment Introduction
13.9.4 Sun Pharmaceutical Revenue in Metastatic Cancer Treatment Business (2015-2020)
13.9.5 Sun Pharmaceutical Recent Development
13.10 Bayer
13.10.1 Bayer Company Details
13.10.2 Bayer Business Overview
13.10.3 Bayer Metastatic Cancer Treatment Introduction
13.10.4 Bayer Revenue in Metastatic Cancer Treatment Business (2015-2020)
13.10.5 Bayer Recent Development
13.11 Gilead Sciences
10.11.1 Gilead Sciences Company Details
10.11.2 Gilead Sciences Business Overview
10.11.3 Gilead Sciences Metastatic Cancer Treatment Introduction
10.11.4 Gilead Sciences Revenue in Metastatic Cancer Treatment Business (2015-2020)
10.11.5 Gilead Sciences Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Metastatic Cancer Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Metastatic Cancer Treatment Revenue
Table 3. Ranking of Global Top Metastatic Cancer Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Metastatic Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Radiation Therapy
Table 7. Key Players of Biologic Targeted Therapy
Table 8. Key Players of Breast Surgery
Table 9. Key Players of Hormone Therapy
Table 10. Global Metastatic Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Metastatic Cancer Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Metastatic Cancer Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Metastatic Cancer Treatment Market Share by Regions (2015-2020)
Table 14. Global Metastatic Cancer Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Metastatic Cancer Treatment Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Metastatic Cancer Treatment Market Growth Strategy
Table 20. Main Points Interviewed from Key Metastatic Cancer Treatment Players
Table 21. Global Metastatic Cancer Treatment Revenue by Players (2015-2020) (Million US$)
Table 22. Global Metastatic Cancer Treatment Market Share by Players (2015-2020)
Table 23. Global Top Metastatic Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Cancer Treatment as of 2019)
Table 24. Global Metastatic Cancer Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Metastatic Cancer Treatment Product Solution and Service
Table 27. Date of Enter into Metastatic Cancer Treatment Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Metastatic Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 30. Global Metastatic Cancer Treatment Market Size Share by Type (2015-2020)
Table 31. Global Metastatic Cancer Treatment Revenue Market Share by Type (2021-2026)
Table 32. Global Metastatic Cancer Treatment Market Size Share by Application (2015-2020)
Table 33. Global Metastatic Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 34. Global Metastatic Cancer Treatment Market Size Share by Application (2021-2026)
Table 35. North America Key Players Metastatic Cancer Treatment Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Metastatic Cancer Treatment Market Share (2019-2020)
Table 37. North America Metastatic Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 38. North America Metastatic Cancer Treatment Market Share by Type (2015-2020)
Table 39. North America Metastatic Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. North America Metastatic Cancer Treatment Market Share by Application (2015-2020)
Table 41. Europe Key Players Metastatic Cancer Treatment Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Metastatic Cancer Treatment Market Share (2019-2020)
Table 43. Europe Metastatic Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Metastatic Cancer Treatment Market Share by Type (2015-2020)
Table 45. Europe Metastatic Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Metastatic Cancer Treatment Market Share by Application (2015-2020)
Table 47. China Key Players Metastatic Cancer Treatment Revenue (2019-2020) (Million US$)
Table 48. China Key Players Metastatic Cancer Treatment Market Share (2019-2020)
Table 49. China Metastatic Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. China Metastatic Cancer Treatment Market Share by Type (2015-2020)
Table 51. China Metastatic Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. China Metastatic Cancer Treatment Market Share by Application (2015-2020)
Table 53. Japan Key Players Metastatic Cancer Treatment Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Metastatic Cancer Treatment Market Share (2019-2020)
Table 55. Japan Metastatic Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Metastatic Cancer Treatment Market Share by Type (2015-2020)
Table 57. Japan Metastatic Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Metastatic Cancer Treatment Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Metastatic Cancer Treatment Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Metastatic Cancer Treatment Market Share (2019-2020)
Table 61. Southeast Asia Metastatic Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Metastatic Cancer Treatment Market Share by Type (2015-2020)
Table 63. Southeast Asia Metastatic Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Metastatic Cancer Treatment Market Share by Application (2015-2020)
Table 65. India Key Players Metastatic Cancer Treatment Revenue (2019-2020) (Million US$)
Table 66. India Key Players Metastatic Cancer Treatment Market Share (2019-2020)
Table 67. India Metastatic Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. India Metastatic Cancer Treatment Market Share by Type (2015-2020)
Table 69. India Metastatic Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. India Metastatic Cancer Treatment Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Metastatic Cancer Treatment Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Metastatic Cancer Treatment Market Share (2019-2020)
Table 73. Central & South America Metastatic Cancer Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Metastatic Cancer Treatment Market Share by Type (2015-2020)
Table 75. Central & South America Metastatic Cancer Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Metastatic Cancer Treatment Market Share by Application (2015-2020)
Table 77. Roche Company Details
Table 78. Roche Business Overview
Table 79. Roche Product
Table 80. Roche Revenue in Metastatic Cancer Treatment Business (2015-2020) (Million US$)
Table 81. Roche Recent Development
Table 82. Novartis Company Details
Table 83. Novartis Business Overview
Table 84. Novartis Product
Table 85. Novartis Revenue in Metastatic Cancer Treatment Business (2015-2020) (Million US$)
Table 86. Novartis Recent Development
Table 87. Merck Company Details
Table 88. Merck Business Overview
Table 89. Merck Product
Table 90. Merck Revenue in Metastatic Cancer Treatment Business (2015-2020) (Million US$)
Table 91. Merck Recent Development
Table 92. Eli Lilly Company Details
Table 93. Eli Lilly Business Overview
Table 94. Eli Lilly Product
Table 95. Eli Lilly Revenue in Metastatic Cancer Treatment Business (2015-2020) (Million US$)
Table 96. Eli Lilly Recent Development
Table 97. Johnson & Johnson Company Details
Table 98. Johnson & Johnson Business Overview
Table 99. Johnson & Johnson Product
Table 100. Johnson & Johnson Revenue in Metastatic Cancer Treatment Business (2015-2020) (Million US$)
Table 101. Johnson & Johnson Recent Development
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer Product
Table 105. Pfizer Revenue in Metastatic Cancer Treatment Business (2015-2020) (Million US$)
Table 106. Pfizer Recent Development
Table 107. AstraZeneca Company Details
Table 108. AstraZeneca Business Overview
Table 109. AstraZeneca Product
Table 110. AstraZeneca Revenue in Metastatic Cancer Treatment Business (2015-2020) (Million US$)
Table 111. AstraZeneca Recent Development
Table 112. GlaxoSmithKline Business Overview
Table 113. GlaxoSmithKline Product
Table 114. GlaxoSmithKline Company Details
Table 115. GlaxoSmithKline Revenue in Metastatic Cancer Treatment Business (2015-2020) (Million US$)
Table 116. GlaxoSmithKline Recent Development
Table 117. Sun Pharmaceutical Company Details
Table 118. Sun Pharmaceutical Business Overview
Table 119. Sun Pharmaceutical Product
Table 120. Sun Pharmaceutical Revenue in Metastatic Cancer Treatment Business (2015-2020) (Million US$)
Table 121. Sun Pharmaceutical Recent Development
Table 122. Bayer Company Details
Table 123. Bayer Business Overview
Table 124. Bayer Product
Table 125. Bayer Revenue in Metastatic Cancer Treatment Business (2015-2020) (Million US$)
Table 126. Bayer Recent Development
Table 127. Gilead Sciences Company Details
Table 128. Gilead Sciences Business Overview
Table 129. Gilead Sciences Product
Table 130. Gilead Sciences Revenue in Metastatic Cancer Treatment Business (2015-2020) (Million US$)
Table 131. Gilead Sciences Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Cancer Treatment Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Radiation Therapy Features
Figure 4. Biologic Targeted Therapy Features
Figure 5. Breast Surgery Features
Figure 6. Hormone Therapy Features
Figure 7. Global Metastatic Cancer Treatment Market Share by Application: 2020 VS 2026
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Other Case Studies
Figure 11. Metastatic Cancer Treatment Report Years Considered
Figure 12. Global Metastatic Cancer Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Metastatic Cancer Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Metastatic Cancer Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Metastatic Cancer Treatment Market Share by Players in 2019
Figure 17. Global Top Metastatic Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Cancer Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Metastatic Cancer Treatment Revenue in 2019
Figure 19. North America Metastatic Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Metastatic Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Metastatic Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Metastatic Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Metastatic Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Metastatic Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Metastatic Cancer Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
転移性膵臓がん治療の世界市場（～2026年） Metastatic pancreatic cancer treatment, when cancer spreads outside of the pancreas, surgery may or may not be recommended. It’s more common for oncologists to recommend systemic treatments (which can circulate throughout the entire body and destroy cancerous cells in multiple locations) for metasta…- 転移性大腸癌手術の世界市場（～2026年） Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body part…
- HER2陰性乳がん治療の世界市場（～2026年） HER2 (human epidermal growth factor receptor 2) is a protein that appears on the surface of some breast cancer cells. It may also be called HER2/neu or ErbB2.HER2-negative breast cancer means that the people have little or no HER2 protein. Market Analysis and Insights: Global HER2-negative breast ca…
- 非血液がん治療の世界市場（～2026年） Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient. North America has the huge number of population suffering fr…
- 膵臓がん治療の世界市場（～2026年） Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …